Published in PLoS One on August 26, 2009
BAP1 and cancer. Nat Rev Cancer (2013) 2.23
Positive reciprocal regulation of ubiquitin C-terminal hydrolase L1 and beta-catenin/TCF signaling. PLoS One (2009) 1.06
Ubiquitin editing enzyme UCH L1 and microtubule dynamics: implication in mitosis. Cell Cycle (2010) 0.96
The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7. J Virol (2010) 0.96
Ubiquitin C-terminal hydrolase l1 in tumorigenesis. Biochem Res Int (2012) 0.93
Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation. Mol Cancer (2011) 0.88
Ubiquitin carboxyl terminal hydrolase L1 negatively regulates TNFalpha-mediated vascular smooth muscle cell proliferation via suppressing ERK activation. Biochem Biophys Res Commun (2009) 0.87
Urea transporter UT-B deletion induces DNA damage and apoptosis in mouse bladder urothelium. PLoS One (2013) 0.81
Ubiquitin C-terminal hydrolase-L1 increases cancer cell invasion by modulating hydrogen peroxide generated via NADPH oxidase 4. Oncotarget (2015) 0.78
Silencing of UCHL1 by CpG promoter hyper-methylation is associated with metastatic gastroenteropancreatic well-differentiated neuroendocrine (carcinoid) tumors. Ann Surg Oncol (2014) 0.77
KSHV LANA and EBV LMP1 induce the expression of UCH-L1 following viral transformation. Virology (2013) 0.77
Ubiquitin carboxyl terminal hydrolyase L1-suppressed autophagic degradation of p21WAF1/Cip1 as a novel feedback mechanism in the control of cardiac fibroblast proliferation. PLoS One (2014) 0.76
Ubiquitin carboxy-terminal hydrolase L1 may be involved in the development of mammary phyllodes tumors. Virchows Arch (2013) 0.76
Quantitative Proteomics Analysis of the Hepatitis C Virus Replicon High-Permissive and Low-Permissive Cell Lines. PLoS One (2015) 0.75
G1 cell-cycle control and cancer. Nature (2004) 5.72
The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science (1989) 3.84
Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J (1997) 3.34
The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell (2002) 3.21
Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum Mol Genet (2003) 2.24
Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist Updat (2007) 2.21
The role of c-myc in cellular growth control. Oncogene (1999) 2.14
Isolation of PGP 9.5, a new human neurone-specific protein detected by high-resolution two-dimensional electrophoresis. J Neurochem (1983) 1.80
The functions of UCH-L1 and its relation to neurodegenerative diseases. Neurochem Int (2007) 1.77
Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines. Proc Natl Acad Sci U S A (1982) 1.73
From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway. J Cell Biochem (2007) 1.65
Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr Mol Med (2003) 1.54
Ingenuity network-assisted transcription profiling: Identification of a new pharmacologic mechanism for MK886. Clin Cancer Res (2006) 1.31
Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis. Oncogene (2008) 1.23
Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer. Int J Cancer (2008) 1.21
PGP9.5 as a prognostic factor in pancreatic cancer. Clin Cancer Res (2000) 1.18
Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines. Mol Carcinog (2006) 1.17
Inhibition of G1 to S cell cycle progression by BCCIP beta. Cell Cycle (2004) 1.12
The role of ubiquitin-proteasome pathway in oncogenic signaling. Cancer Biol Ther (2002) 1.11
Fibronectin in malignancy. Semin Cancer Biol (2002) 1.10
Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1). Oncogene (2002) 1.10
Role of the cytoskeletal protein paxillin in oncogenesis. Crit Rev Oncog (2000) 1.09
Positive reciprocal regulation of ubiquitin C-terminal hydrolase L1 and beta-catenin/TCF signaling. PLoS One (2009) 1.06
Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus. J Virol (1999) 1.04
High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer. Cancer Sci (2006) 0.99
Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A. Prostate (2007) 0.97
RhoA protein expression correlates positively with degree of malignancy in astrocytomas. Neurosci Lett (2006) 0.96
Protein gene product 9.5 (PGP 9.5) is not a specific marker of neural and nerve sheath tumors: an immunohistochemical study of 95 mesenchymal neoplasms. Mod Pathol (2003) 0.96
Oxidative stress regulated expression of ubiquitin Carboxyl-terminal Hydrolase-L1: role in cell survival. Apoptosis (2006) 0.95
Ubiquitin COOH-terminal hydrolase 1: a biomarker of renal cell carcinoma associated with enhanced tumor cell proliferation and migration. Clin Cancer Res (2007) 0.94
PGP9.5 methylation as a marker for metastatic colorectal cancer. Anticancer Res (2008) 0.91
Expression of the protein gene product 9.5, PGP9.5, is correlated with T-status in non-small cell lung cancer. Jpn J Clin Oncol (2001) 0.91
The ubiquitin C-terminal hydrolase UCH-L1 regulates B-cell proliferation and integrin activation. J Cell Mol Med (2009) 0.90
PGP9.5 overexpression in esophageal squamous cell carcinoma. Hepatogastroenterology (2003) 0.90
Identifying apoptosis-evasion proteins/pathways in human hepatoma cells via induction of cellular hormesis by UV irradiation. J Proteome Res (2009) 0.89
Endoplasmic reticulum stress contributes to the cell death induced by UCH-L1 inhibitor. Mol Cell Biochem (2008) 0.85
PGP9.5 mRNA could contribute to the molecular-based diagnosis of medullary thyroid carcinoma. Eur J Cancer (2004) 0.84
Stimulation of the murine Uchl1 gene promoter by the B-Myb transcription factor. Lung Cancer (2003) 0.84
Microarray expression analysis of gad mice implicates involvement of Parkinson's disease associated UCH-L1 in multiple metabolic pathways. Brain Res Mol Brain Res (2004) 0.80
Plasminogen activator inhibitor-1 is a downstream mediator of the PGP9.5-related oncogenic pathway in esophageal squamous cell carcinoma. Anticancer Res (2005) 0.77
Bryostatin 1 induces ubiquitin COOH-terminal hydrolase in acute lymphoblastic leukemia cells. Enzyme Protein (1996) 0.77
Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res (2007) 1.69
Structure and function of IRF-7. J Interferon Cytokine Res (2002) 1.53
The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res (2004) 1.50
Regulation of the transcriptional activity of the IRF7 promoter by a pathway independent of interferon signaling. J Biol Chem (2005) 1.45
Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit. J Virol (2003) 1.42
Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha. Mol Cell Biol (2004) 1.33
EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells. Cancer Res (2006) 1.31
Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the L-riboside benzimidazole 1263W94. J Virol (2002) 1.30
Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res (2007) 1.26
TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1. Mol Cell Biol (2008) 1.25
Epstein-Barr virus-encoded protein kinase (BGLF4) is involved in production of infectious virus. J Virol (2007) 1.23
Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination. Mol Cell Biol (2007) 1.23
Conserved herpesvirus protein kinases. Biochim Biophys Acta (2007) 1.17
Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter. J Virol (2005) 1.15
Targeting of host-cell ubiquitin pathways by viruses. Essays Biochem (2005) 1.14
The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production. J Virol (2010) 1.12
Tissue regeneration in vivo within recombinant spidroin 1 scaffolds. Biomaterials (2012) 1.12
Epstein-Barr virus latent membrane protein 1 induces cancer stem/progenitor-like cells in nasopharyngeal epithelial cell lines. J Virol (2011) 1.11
Epstein-Barr virus activates beta-catenin in type III latently infected B lymphocyte lines: association with deubiquitinating enzymes. Proc Natl Acad Sci U S A (2003) 1.08
Epstein-Barr virus infections: prospects for treatment. J Antimicrob Chemother (2005) 1.08
The Epstein-Barr virus (EBV) deubiquitinating enzyme BPLF1 reduces EBV ribonucleotide reductase activity. J Virol (2009) 1.06
Positive reciprocal regulation of ubiquitin C-terminal hydrolase L1 and beta-catenin/TCF signaling. PLoS One (2009) 1.06
Interferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic properties. J Virol (2004) 1.05
New associations of human papillomavirus, Simian virus 40, and Epstein-Barr virus with human cancer. J Natl Cancer Inst (2002) 1.03
Tumor viruses and cell signaling pathways: deubiquitination versus ubiquitination. Mol Cell Biol (2004) 1.02
Multiple signal transducers and activators of transcription are induced by EBV LMP-1. Virology (2004) 1.01
Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma. Int J Cancer (2005) 1.00
Up-regulation of beta-catenin by a viral oncogene correlates with inhibition of the seven in absentia homolog 1 in B lymphoma cells. Proc Natl Acad Sci U S A (2005) 1.00
MUC1 induced by Epstein-Barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling. J Virol (2006) 0.99
Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit. J Virol (2005) 0.98
Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2. Cancer Res (2002) 0.98
Epstein-Barr virus latent membrane protein 1 promotes concentration in multivesicular bodies of fibroblast growth factor 2 and its release through exosomes. Int J Cancer (2007) 0.98
Maribavir inhibits epstein-barr virus transcription in addition to viral DNA replication. J Virol (2009) 0.97
Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1. J Virol (2005) 0.96
Ubiquitin editing enzyme UCH L1 and microtubule dynamics: implication in mitosis. Cell Cycle (2010) 0.96
The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7. J Virol (2010) 0.96
Epstein-Barr virus BPLF1 deubiquitinates PCNA and attenuates polymerase η recruitment to DNA damage sites. J Virol (2012) 0.94
Transforming growth factor beta/Smad3 signaling regulates IRF-7 function and transcriptional activation of the beta interferon promoter. Mol Cell Biol (2004) 0.93
Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9. J Virol (2011) 0.90
Epstein-Barr virus induces invasion and metastasis factors. Anticancer Res (2003) 0.90
Effects of maribavir and selected indolocarbazoles on Epstein-Barr virus protein kinase BGLF4 and on viral lytic replication. Antimicrob Agents Chemother (2004) 0.90
Upregulation of special AT-rich-binding protein 1 by Epstein-Barr virus latent membrane protein 1 in human nasopharyngeal cells and nasopharyngeal cancer. J Gen Virol (2012) 0.89
Mitosis-specific hyperphosphorylation of Epstein-Barr virus nuclear antigen 2 suppresses its function. J Virol (2004) 0.87
Is Epstein-Barr virus transmitted sexually? J Infect Dis (2007) 0.86
Epstein-Barr virus latent membrane protein 1 regulates the function of interferon regulatory factor 7 by inducing its sumoylation. J Virol (2012) 0.86
Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta. Virology (2010) 0.85
PU.1-dependent regulation of UCH L1 expression in B-lymphoma cells. Leuk Lymphoma (2011) 0.83
Ribonucleotide reductase inhibitors enhance cidofovir-induced apoptosis in EBV-positive nasopharyngeal carcinoma xenografts. Int J Cancer (2005) 0.81
Role of the ubiquitin system and tumor viruses in AIDS-related cancer. BMC Biochem (2007) 0.80
Maribavir inhibits Epstein-Barr virus transcription through the EBV protein kinase. J Virol (2013) 0.80
cdc2/cyclin B1-dependent phosphorylation of EBNA2 at Ser243 regulates its function in mitosis. J Virol (2006) 0.79
The Rad6/18 ubiquitin complex interacts with the Epstein-Barr virus deubiquitinating enzyme, BPLF1, and contributes to virus infectivity. J Virol (2014) 0.78
KSHV LANA and EBV LMP1 induce the expression of UCH-L1 following viral transformation. Virology (2013) 0.77